We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Higher Blood Lead Levels Lower IQ

By LabMedica International staff writers
Posted on 22 May 2013
Children living near toxic waste sites may experience higher blood lead levels, resulting in a loss of intelligence quotient (IQ) points. More...


Children from lower and middle-income countries in Asia who live near such sites may also suffer a higher incidence of mental retardation.

Scientists at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) collaborating with the Blacksmith Institute (New York, NY, USA) measured lead levels in soil and drinking water at 200 toxic waste sites in 31 countries then estimated the blood lead levels in 779,989 children who were potentially exposed to lead from these sites in 2010.

The blood lead levels ranged from 1.5 to 104 µg/dL, with an average of 21 µg/dL in children ages four years and younger. The average blood lead level in an American child is approximately 1.3 µg/dL. These higher blood lead levels could result in an estimated loss of five to eight IQ points per child and an incidence of mild mental retardation in six out of every 1,000 children. The condition of mental retardation is defined as having an IQ below 70.

Kevin Chatham-Stephens, MD, Pediatric Environmental Health Fellow and coauthor of the study, said, “We found an average predicted blood lead level of 21 µg/dL, which is very high. Lead has serious, long-term health consequences such as the potential to impair cognitive development in children and cause mental retardation. We have shown that children who were chronically exposed to toxic waste sites in lower and middle income countries could have had high lead blood levels."

Philip Landrigan, MD, MSc, Dean for Global Health at the Icahn School of Medicine and coauthor of the study, said, “On a global level, this analysis highlights the importance of assigning more public health resources to identify, evaluate and remediate lead-contaminated toxic waste sites in countries like India, Philippines and Indonesia. In order to prevent further detrimental effects on neurodevelopment in children, these countries should create programs to identify toxic wastes and reduce lead exposure." The study was presented on May 6, 2013, at the Pediatric Academic Societies (PAS) annual meeting held in Washington DC (USA).

Related Links:
Icahn School of Medicine at Mount Sinai
Blacksmith Institute



New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.